How much did Terumo achieve in EBIT for the current year?
In the current year, Terumo has achieved an EBIT of 166.65 B JPY.
Terumo EBIT 2025
Terumo EBIT
166.65 B JPY
Ticker
4543.T
ISIN
JP3546800008
WKN
867003
In 2025, Terumo's EBIT was 166.65 B JPY, a 16.52% increase from the 143.03 B JPY EBIT recorded in the previous year.
The Terumo EBIT history
| YEAR | EBIT (undefined JPY) |
|---|---|
| 2027e | 225.23 |
| 2026e | 191.9 |
| 2025e | 166.65 |
| 2024 | 143.03 |
| 2023 | 119.79 |
| 2022 | 116.66 |
| 2021 | 97.44 |
| 2020 | 108.59 |
| 2019 | 99.05 |
| 2018 | 106.13 |
| 2017 | 89.87 |
| 2016 | 81.7 |
| 2015 | 67.46 |
| 2014 | 65.29 |
| 2013 | 53.22 |
| 2012 | 63.05 |
| 2011 | 62.61 |
| 2010 | 63.28 |
| 2009 | 54.04 |
| 2008 | 66.94 |
| 2007 | 58.46 |
| 2006 | 48.25 |
| 2005 | 44.93 |
Terumo Revenue, EBIT, Net Income JP3546800008 · 867003
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Terumo, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Terumo from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Terumo’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Terumo. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Terumo’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Terumo’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Terumo’s growth potential.
Terumo Revenue, EBIT and net profit per share
| Date | Terumo Revenue | Terumo EBIT | Terumo Net Income |
|---|---|---|---|
| 2027e | 1.19 T undefined | 225.23 B undefined | 173.78 B undefined |
| 2026e | 1.11 T undefined | 191.9 B undefined | 154.51 B undefined |
| 2025e | 1.04 T undefined | 166.65 B undefined | 130.42 B undefined |
| 2024 | 921.86 B undefined | 143.03 B undefined | 106.37 B undefined |
| 2023 | 820.21 B undefined | 119.79 B undefined | 89.33 B undefined |
| 2022 | 703.3 B undefined | 116.66 B undefined | 88.81 B undefined |
| 2021 | 613.84 B undefined | 97.44 B undefined | 77.27 B undefined |
| 2020 | 628.9 B undefined | 108.59 B undefined | 85.21 B undefined |
| 2019 | 599.48 B undefined | 99.05 B undefined | 79.47 B undefined |
| 2018 | 587.78 B undefined | 106.13 B undefined | 91.3 B undefined |
| 2017 | 514.16 B undefined | 89.87 B undefined | 55 B undefined |
| 2016 | 525.03 B undefined | 81.7 B undefined | 50.68 B undefined |
| 2015 | 489.51 B undefined | 67.46 B undefined | 38.47 B undefined |
| 2014 | 467.36 B undefined | 65.29 B undefined | 34.1 B undefined |
| 2013 | 402.29 B undefined | 53.22 B undefined | 47.01 B undefined |
| 2012 | 386.69 B undefined | 63.05 B undefined | 24.17 B undefined |
| 2011 | 328.21 B undefined | 62.61 B undefined | 32.34 B undefined |
| 2010 | 316.01 B undefined | 63.28 B undefined | 40.72 B undefined |
| 2009 | 302.75 B undefined | 54.04 B undefined | 36.88 B undefined |
| 2008 | 306.38 B undefined | 66.94 B undefined | 43.38 B undefined |
| 2007 | 276.44 B undefined | 58.46 B undefined | 37.23 B undefined |
| 2006 | 247.05 B undefined | 48.25 B undefined | 32.33 B undefined |
| 2005 | 230 B undefined | 44.93 B undefined | 26.98 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 230 B JPY | 44.93 B JPY | 26.98 B JPY |
| 2006 | 247.05 B JPY | 48.25 B JPY | 32.33 B JPY |
| 2007 | 276.44 B JPY | 58.46 B JPY | 37.23 B JPY |
| 2008 | 306.38 B JPY | 66.94 B JPY | 43.38 B JPY |
| 2009 | 302.75 B JPY | 54.04 B JPY | 36.88 B JPY |
| 2010 | 316.01 B JPY | 63.28 B JPY | 40.72 B JPY |
| 2011 | 328.21 B JPY | 62.61 B JPY | 32.34 B JPY |
| 2012 | 386.69 B JPY | 63.05 B JPY | 24.17 B JPY |
| 2013 | 402.29 B JPY | 53.22 B JPY | 47.01 B JPY |
| 2014 | 467.36 B JPY | 65.29 B JPY | 34.1 B JPY |
| 2015 | 489.51 B JPY | 67.46 B JPY | 38.47 B JPY |
| 2016 | 525.03 B JPY | 81.7 B JPY | 50.68 B JPY |
| 2017 | 514.16 B JPY | 89.87 B JPY | 55 B JPY |
| 2018 | 587.78 B JPY | 106.13 B JPY | 91.3 B JPY |
| 2019 | 599.48 B JPY | 99.05 B JPY | 79.47 B JPY |
| 2020 | 628.9 B JPY | 108.59 B JPY | 85.21 B JPY |
| 2021 | 613.84 B JPY | 97.44 B JPY | 77.27 B JPY |
| 2022 | 703.3 B JPY | 116.66 B JPY | 88.81 B JPY |
| 2023 | 820.21 B JPY | 119.79 B JPY | 89.33 B JPY |
| 2024 | 921.86 B JPY | 143.03 B JPY | 106.37 B JPY |
| 2025e | 1.04 T JPY | 166.65 B JPY | 130.42 B JPY |
| 2026e | 1.11 T JPY | 191.9 B JPY | 154.51 B JPY |
| 2027e | 1.19 T JPY | 225.23 B JPY | 173.78 B JPY |
Terumo stock margins JP3546800008 · 867003
The Terumo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Terumo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Terumo.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Terumo's sales revenue. A higher gross margin percentage indicates that the Terumo retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Terumo's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Terumo's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Terumo's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Terumo. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Terumo's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Terumo Margin History
| Terumo Gross margin | Terumo Profit margin | Terumo EBIT margin | Terumo Profit margin |
|---|---|---|---|
| 2027e | 51.98 % | 18.9 % | 14.58 % |
| 2026e | 51.98 % | 17.28 % | 13.91 % |
| 2025e | 51.98 % | 16.07 % | 12.58 % |
| 2024 | 51.98 % | 15.51 % | 11.54 % |
| 2023 | 50.89 % | 14.6 % | 10.89 % |
| 2022 | 52.52 % | 16.59 % | 12.63 % |
| 2021 | 53.21 % | 15.87 % | 12.59 % |
| 2020 | 54.69 % | 17.27 % | 13.55 % |
| 2019 | 54.46 % | 16.52 % | 13.26 % |
| 2018 | 54.33 % | 18.06 % | 15.53 % |
| 2017 | 53.26 % | 17.48 % | 10.7 % |
| 2016 | 53.87 % | 15.56 % | 9.65 % |
| 2015 | 52.3 % | 13.78 % | 7.86 % |
| 2014 | 51.78 % | 13.97 % | 7.3 % |
| 2013 | 51.13 % | 13.23 % | 11.69 % |
| 2012 | 52.92 % | 16.3 % | 6.25 % |
| 2011 | 52.04 % | 19.08 % | 9.85 % |
| 2010 | 52.64 % | 20.03 % | 12.89 % |
| 2009 | 52.27 % | 17.85 % | 12.18 % |
| 2008 | 54.9 % | 21.85 % | 14.16 % |
| 2007 | 55.47 % | 21.15 % | 13.47 % |
| 2006 | 54.92 % | 19.53 % | 13.08 % |
| 2005 | 53.81 % | 19.53 % | 11.73 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 53.81 % | 19.53 % | 11.73 % |
| 2006 | 54.92 % | 19.53 % | 13.08 % |
| 2007 | 55.47 % | 21.15 % | 13.47 % |
| 2008 | 54.9 % | 21.85 % | 14.16 % |
| 2009 | 52.27 % | 17.85 % | 12.18 % |
| 2010 | 52.64 % | 20.03 % | 12.89 % |
| 2011 | 52.04 % | 19.08 % | 9.85 % |
| 2012 | 52.92 % | 16.3 % | 6.25 % |
| 2013 | 51.13 % | 13.23 % | 11.69 % |
| 2014 | 51.78 % | 13.97 % | 7.3 % |
| 2015 | 52.3 % | 13.78 % | 7.86 % |
| 2016 | 53.87 % | 15.56 % | 9.65 % |
| 2017 | 53.26 % | 17.48 % | 10.7 % |
| 2018 | 54.33 % | 18.06 % | 15.53 % |
| 2019 | 54.46 % | 16.52 % | 13.26 % |
| 2020 | 54.69 % | 17.27 % | 13.55 % |
| 2021 | 53.21 % | 15.87 % | 12.59 % |
| 2022 | 52.52 % | 16.59 % | 12.63 % |
| 2023 | 50.89 % | 14.6 % | 10.89 % |
| 2024 | 51.98 % | 15.51 % | 11.54 % |
| 2025e | 51.98 % | 16.07 % | 12.58 % |
| 2026e | 51.98 % | 17.28 % | 13.91 % |
| 2027e | 51.98 % | 18.9 % | 14.58 % |
Terumo Aktienanalyse
What does Terumo do?
Terumo Corporation is a Japanese company that was founded in 1921. The company is headquartered in Tokyo and specializes in the development, manufacturing, and marketing of medical products and devices. It has a global presence and employs approximately 28,000 people in over 160 countries. The company's history began with the establishment of a small medical device company called Sekisen Kenonsha, founded by a group of doctors. In 1942, the company merged with another company named Terumo Sougou Kenkyuusho and became Terumo Corporation. Since then, the company has continuously expanded and diversified its product range. Terumo's business model focuses on providing solutions to improve people's health worldwide through the development of innovative medical devices and products. The company operates in three main business areas: 1. Interventional Systems: This business area specializes in the development of catheters, stent systems, and other medical products for cardiac, peripheral, and vascular interventions. 2. Blood Systems: This business area offers a wide range of products for blood collection and processing, including disposable syringes for blood collection and venous and arterial access systems. 3. Biosciences: This business area focuses on the development of products for cell culture and regenerative medicine, including stem cell therapy and cell banks for research. Terumo distributes its products not only directly to hospitals and medical facilities but also collaborates closely with distributors and partners to reach a wider customer base. Additionally, the company invests significant resources in research and development to continuously expand its product range. Among the products that Terumo offers, some of the most advanced and innovative medical devices on the market can be found. One example is the state-of-the-art catheters and stent systems that enable doctors to perform minimally invasive procedures to treat serious cardiovascular diseases. Terumo also produces disposable syringes that are widely used due to their high quality and reliability. In recent years, Terumo has also invested in regenerative medicine by developing products for cell culture and therapy. This includes stem cell therapy products that can be used in the treatment of certain cancers and blood disorders. Overall, Terumo Corporation has a long history as one of the leading companies in the medical technology industry. With its innovative products and strong focus on research and development, the company will continue to play an important role in improving the health and well-being of people worldwide. Terumo ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Terumo's EBIT
Terumo's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Terumo's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Terumo's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Terumo’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Terumo stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Terumo.
How has the EBIT of Terumo developed in recent years?
The EBIT of Terumo has increased by 16.517% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Terumo?
The EBIT of Terumo is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Terumo pay?
Over the past 12 months, Terumo paid a dividend of 24 JPY . This corresponds to a dividend yield of about 0.89 %. For the coming 12 months, Terumo is expected to pay a dividend of 24.95 JPY.
What is the dividend yield of Terumo?
The current dividend yield of Terumo is 0.89 %.
When does Terumo pay dividends?
Terumo pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Terumo?
Terumo paid dividends every year for the past 23 years.
What is the dividend of Terumo?
For the upcoming 12 months, dividends amounting to 24.95 JPY are expected. This corresponds to a dividend yield of 0.92 %.
In which sector is Terumo located?
Terumo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Terumo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Terumo from 6/1/2025 amounting to 13 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.
When did Terumo pay the last dividend?
The last dividend was paid out on 6/1/2025.
What was the dividend of Terumo in the year 2024?
In the year 2024, Terumo distributed 43 JPY as dividends.
In which currency does Terumo pay out the dividend?
The dividends of Terumo are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Terumo
Our stock analysis for Terumo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Terumo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
